---
schema_version: "secwatch.filing_event.v1"
accession: "0001370053-24-000003"
form_type: "8-K"
ticker: "ANAB"
cik: "0001370053"
company_name: "ANAPTYSBIO, INC"
filed_at: "2024-01-05T23:59:59+00:00"
generated_at: "2026-06-07T03:01:05.308998+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# AnaptysBio expects $417M cash at year-end 2023; presents at JPM Healthcare Conference

## Summary
- Preliminary cash, cash equivalents, and investments of approximately $417M as of December 31, 2023.
- Presentation at J.P. Morgan Healthcare Conference on January 8, 2024; full corporate overview furnished as Exhibit 99.1.
- Audited FY2023 financials not yet available; preliminary estimate subject to adjustment.
- Presentation details (pipeline, clinical data) not fully available in the provided exhibit excerpt.

## SEC filing metadata
- accession: 0001370053-24-000003
- form_type: 8-K
- ticker: ANAB
- cik: 0001370053
- company_name: ANAPTYSBIO, INC
- filed_at: 2024-01-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1370053/000137005324000003/0001370053-24-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1370053/000137005324000003/anab-20240105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001370053-24-000003
- JSON: https://secwatch.observer/filing/0001370053-24-000003.json
- Plain text: https://secwatch.observer/filing/0001370053-24-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.